Clinical Trial Update: Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

View source ↗

Summary

This clinical trial update describes a study using chromatic pupillometry to assess the melanopsin-light pathway in Progressive Supranuclear Palsy, with related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Parkinson Disease
• Progressive Supranuclear Palsy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: PSP - Progressive Supranuclear Palsy, PD - Parkinson's Disease | Status: UNKNOWN